ISPC (iSpecimen) Insider Ownership: 21.95 % (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISPC iSpecimen Inc ISPC
35 GF Score
Price $1.69
GF Value $0.34
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is iSpecimen Insider Ownership?

iSpecimen ISPC -26.20% 35 Insider Ownership is 21.95 % as of Aug. 22, 2026. GuruFocus rates ISPC with a GF Score™ of 35/100 and a GF Value™ of $0.34 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, iSpecimen's insider ownership is 21.95%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, iSpecimen's Institutional Ownership is 1.50%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, iSpecimen's Float Percentage Of Total Shares Outstanding is 99.94%.

iSpecimen Insider Ownership Historical Data

* Premium members only.

The historical data trend for iSpecimen's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iSpecimen Insider Ownership Chart

iSpecimen Historical Data

The historical data trend for iSpecimen can be seen below:

2025-04-30 2025-05-31 2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28
Insider Ownership 85.90 85.90 85.90 85.90 38.72 26.12 21.95 21.95 21.95 21.95
ISPC
35GF Score
iSpecimen Inc ISPC
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iSpecimen Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 21.95 % mean?
iSpecimen (ISPC) has a Insider Ownership of 21.95 % as of Aug. 22, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on iSpecimen and its competitors.
Is iSpecimen's Insider Ownership too high?
iSpecimen's current Insider Ownership is 21.95 %. Overall, iSpecimen has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iSpecimen's Insider Ownership compare to FUNI and BIAF?
iSpecimen's Insider Ownership of 21.95 % can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Diagnostics & Research company?
A good Insider Ownership depends on the Medical Diagnostics & Research industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on iSpecimen and its competitors. iSpecimen's current Insider Ownership is 21.95 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iSpecimen stock overvalued right now?
Based on GuruFocus' analysis, iSpecimen (ISPC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.34, compared to a current price of $1.69 — trading 397.1% above its estimated fair value. The current Insider Ownership is 21.95 %. iSpecimen's overall GF Score™ is 35/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For iSpecimen (ISPC), the current Insider Ownership is 21.95 % as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iSpecimen (ISPC) Overvalued in 2026?

Based on GuruFocus' analysis, iSpecimen stock appears to be overvalued. The current stock price of $1.69 is trading 397.1% above its estimated GF Value™ of $0.34. GuruFocus considers iSpecimen to be Significantly Overvalued.

Key valuation signals for ISPC:

  • Insider Ownership: 21.95 %
  • GF Value™: $0.34 vs. price of $1.69 (397.1% above fair value)
  • GF Score™: 35/100 with 7 warning signs

No single metric tells the full story. See the ISPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iSpecimen Business Description

Address 8 Cabot Road, Suite 1800, Woburn, MA, USA, 01801
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
35GF Score

Get the complete analysis for ISPC

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.69
Price
$0.34
GF Value